Olivier Noel is a 2017 Forbes Magazine 30 Under 30 honoree in Science. Olivier has been conducting developmental biology and biomedical science research for over 8 years. He was an American Heart Association and National Institute of Health fellow and has been featured in the New York Daily News, CBS radio, and other news outlets for his academic and entrepreneurial achievements. Olivier grew up in Haiti and moved to Queens, NY, where he attended Queens College. He graduated in 2011 with a major in chemistry with a concentration in biochemistry and honors in biomedical science research. In 2011, he began training in the Penn State University MSTP MD/PhD program, getting a PhD in biochemistry and molecular genetics. His current research focuses on identifying the genetics behind the positive health effects following bariatric surgery in patients and developing novel therapies for diabetic patients.
Tarik graduated with a degree in Physics from Penn State University. He is an MD/PhD student, currently getting his PhD in Bioinformatics and Computational Genetics. He has written various pipelines for genomic research teams to analyze sequencing data. His current research focuses on the effects of genetic variants on treatment responses.
Jeff is a computer scientist specializing in artificial intelligence. He enrolled at Brown University before transferring to Penn State, where he graduated with four degrees from the Schreyer Honors College. After teaching math in China and Cambodia, he attained a master's degree in computer science from Drexel University. He has written artificial intelligence (AI) programs for high-profile companies and led a research team at Carnegie Mellon University which tied eight AI world records.
Dr. Wafik El-Deiry is an American Cancer Society Research Professor, Deputy Director for Translational Research and co-Program Leader in Developmental Therapeutics and William Wikoff Smith Endowed Chair in Cancer Research at the Fox Chase Cancer Center. He made several discoveries in the field of cell death and tumor suppressor genes, including discovery of TRAIL death receptor DR5 as a target of the p53 tumor suppressor. Dr. El-Deiry leads the Fox Chase translational research efforts and continues his work in the world of translational drug discovery and development. You can read more at his full biographical page.
Dr. Nathalia Glickman Holtzman is an Associate Professor of Biology and Associate Director at the Center for Teaching and Learning at Queens College. Her lab is interested in organogenesis with a focus on heart development. Specifically, her research interests include understanding the interactions between the endocardium and myocardium during heart tube formation, cardiac maturation, and epicardial formation and maturation. You can read more at her research homepage.
Gia is currently pursuing a master’s degree in public health at the University of Pennsylvania with an emphasis in health communications. She studied creative writing and medical humanities at Sarah Lawrence College in Bronxville, New York, before returning to her hometown of San Francisco to work for Berkshire Hathaway. Since beginning her studies in Philadelphia, she has worked at Griot Digital and Wharton Student Computing.
Yuge is a first-year undergraduate at Columbia University. There, she is pursuing a major in biomedical engineering and a minor in computer science. She serves as a board member of the university’s Biomedical Engineering Society chapter. Aside from her love of the sciences, Yuge also enjoys journalism and has written pieces for The Philadelphia Inquirer. An avid athlete, she competes for Columbia’s tae kwon do and ultimate frisbee teams.
Suzanne is in her second year at Syracuse University. She is studying Writing, Rhetoric & Discourse and is also pursuing a minor in Italian. She has also written for several Syracuse University student-run publications such as Juiced Magazine and HerCampus SU. Aside from her love of writing, Suzanne also enjoys fishing and surfing along New Jersey’s coast.